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Abstract
Background: Prior to the 2007–2010 Q fever epidemic in the Netherlands, the seroprevalence of antibodies against
Coxiella burnetii in the general population was 1.5%, which is low compared to other countries. We aimed to
determine the seroprevalence after the Q fever epidemic among people living in the affected area, compare the
seroprevalence with the incidence of Q fever notifications during the 2007–2010 Q fever epidemic, and to identify
farm exposures associated with having antibodies against C. burnetii.
Methods: During the period March 2014–February 2015, residents aged 18–70 years from two provinces were
invited by general practitioners to complete a questionnaire on their symptoms and personal characteristics and to
submit a blood sample. We used the mandatory provincial database of livestock licences to calculate distance to
farms/farm animals for each participant. To compare ELISA-positive participants for C. burnetii antibodies with those
who were negative, we calculated prevalence ratios (PR) using binominal regression. We compared the C. burnetii
seroprevalence in the period March 2014–February 2015 with the incidence of Q fever notifications during the
2007–2010 Q fever epidemic at municipal level by calculating the Spearman correlation coefficient.
Results: Of the 2296 participants (response rate: 34%), 6.1% (n = 139, 95% CI 5.1–7.1%) had C. burnetii antibodies
(range in municipalities: 1.7–14.1%). C. burnetii seroprevalence was higher in individuals living within 1000 m of
goat farms (PR 3.0; 95% CI 1.4–6.4) or within 1000 m of > 50 goats (PR 1.9; 95% CI 1.2–3.0). Seroprevalence
increased with decreasing distance to the closest goat farm that was infected during the epidemic years
(< 500 m, PR 9.5, 95% CI 2.8–32; 500–1000 m, PR 4.5, 95% CI 2.6–7.7; 1000–1500 m, PR 2.2, 95% CI 1.1–4.3,
1500–2000 m, PR 1.2, 95% CI 0.6–2.5; > 2000 reference group). There was no significant correlation between
C. burnetii seroprevalence and Q fever incidence during the 2007–2010 epidemic (rs = 0.42, p = 0.156).
Conclusions: Results showed a remarkable spatial variation in C. burnetii seroprevalence in a relatively small
livestock dense area. It confirms previous evidence that the Q fever epidemic was primarily the result of airborne
C. burnetii transmission from Q fever affected goat farms.
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Background
Q fever is a zoonosis caused by the intracellular bacter-
ium Coxiella burnetii. The most common reservoirs for
C. burnetii are goats, sheep and cattle, although a variety
of other species can get infected [1]. In goats and sheep,
the main clinical symptom of Q fever is abortion and in
cattle reduced fertility but most animals remain asymp-
tomatic. Animals shed C. burnetii in milk, faeces, urine
and especially in birth materials [2]. Humans typically
acquire the infection through the inhalation of contami-
nated aerosols, with approximately 60% of the infected
remaining asymptomatic [3, 4]. In symptomatic patients,
acute Q fever usually presents as an influenza-like febrile
illness, pneumonia, or hepatitis.
The 2007–2010 Q fever epidemic in the Netherlands
with over 4000 notified human cases was a major public
health event [5] and resulted in increased concern about
possible health risks for the general population living in
livestock dense areas [6]. The epicentre of the Q fever epi-
demic was in the province of Noord-Brabant, which
in 2007 had particularly high densities of poultry
(5024 animals/km2), cattle (125 animals/km2), goats
(23 animals/km2) and sheep (20 animals/km2) [7].
Since 2009, there is an ongoing mandatory annual
vaccination programme for dairy goats and dairy
sheep on farms with more than 50 animals and the
number of acute Q fever notifications is back at the
level it was before 2007 [8].
Prior to the Q fever epidemic, the seroprevalence was
estimated at 1.5% in the general population of the
Netherlands in 2006 using an enzyme-linked immuno-
sorbent assay (ELISA) [9]. This was corrected to 2.4% by
confirmation on a subset using immunofluorescence
assay (IFA), which is considered the reference method
for diagnostic screening for C. burnetii antibodies. Even
2.4% is a low seroprevalence figure compared to many
other countries. For example, a community-based study
conducted in the USA showed a seroprevalence of 3.1%
using IFA [10]. A study among blood donors in France
in 1988 and in Japan in the late 1990s showed a sero-
prevalence of 4.0% and 3.6%, respectively, both using
IFA [11, 12]. The dynamics of antibodies against C. bur-
netii and the role of changing or repeated exposure, are
still poorly understood. Historically, there is evidence
that the seroprevalence was much higher in the
Netherlands in the 1980s [17].
To gain more insight in the dynamics of C. burnetii
seroprevalence, we conducted a serological survey for
antibodies against C. burnetii among people living in a
livestock-dense area in the south of the Netherlands
where the epidemic occurred. The aims were to 1) deter-
mine the seroprevalence of antibodies against C. burnetii
among people living in the area affected by the Q fever
epidemic several years after the epidemic; 2) compare
the C. burnetii seroprevalence with the incidence of Q
fever notifications during the 2007–2010 Q fever epi-
demic; and 3) to identify farm exposures associated with
having antibodies against C. burnetii.
Methods
Study design and population
This cross-sectional population-based serological sur-
vey took place as part of the ‘Livestock Farming and
Neighbouring Residents’ Health’ study (VGO). For
details about the recruitment of the VGO population,
we refer to previously published papers [13, 14].
Briefly, a survey was conducted among 14,163 adults
aged 20–72 years from the general population after a
two-stage selection procedure. First, general practi-
tioners were recruited and selected based on registra-
tion quality criteria; then all patients of the selected
general practitioners were invited [13]. Participants
who gave their consent for further contact for add-
itional studies and who were not working or living
on a farm, were eligible for the medical survey.
Based on their home addresses, 12 temporary re-
search centres were established. All participants liv-
ing within approximately 10 km of a temporary
research centre were invited to participate in the
study (a total of 7180 people aged 20–72 years) [14].
Of those, 2494 (response rate 35%) participated in a
medical examination at one of 12 temporary study
centres. Serum samples were obtained from 2422
participants.
Animal exposure assessment
Farm locations and number and type(s) of animals
per farm were obtained from the provincial database
of mandatory environmental licences for keeping
livestock (BVB) for the year 2012. These data were
used to calculate the distances to farms for each par-
ticipant based on their residential address. Several
exposure variables were defined, such as the presence
of animal farms (binary), and the total number of
sheep, goat (categorized as more or less than 50
goats/sheep, i.e. the cut-off for mandatory vaccin-
ation) and cattle (tertiles) within 500 m and 1000 m
of the participants’ residential address. Exposure was
based on the presence of a Q fever affected dairy
goat farm near the residential address (categorized as
< 500 m, 500–1000 m, 1000–1500 m, 1500–2000 m,
with > 2000 m being the reference). A dairy goat
farm was considered affected when it had
experienced abortion waves between 2005 and 2009
(data provided by the GD Animal Health) or when
they tested positive for Q fever in the mandatory
bulk tank milk monitoring system using PCR for the
detection of C. burnetii DNA that was implemented
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in 2009 and is still ongoing (data from the Food and
Consumer Product Safety Authority). Q fever on
farms experiencing abortion waves was confirmed
with immunohistochemistry.
Data collection
Subjects completed a questionnaire including items on
respiratory health, residential characteristics, smoking
habits, education, occupation, and animal contact. Ques-
tionnaire data and serum samples were collected from
10 March 2014 to 27 February 2015 [15]. All study
centres were in the eastern part of the province of
Noord-Brabant and the northern part of the province of
Limburg (Fig. 1). These were the provinces most affected
by the Q fever epidemic [5].
Q fever notifications
Q fever is a notifiable disease in the Netherlands and in-
formation on human data is stored in an electronic data-
base at the National Institute for Public Health and the
Environment (RIVM). We used data on human Q fever
cases that were notified during the 2007–2010 Q fever
epidemic. Cases were assigned to a municipality based
on the participants’ place of residence.
Laboratory analysis
Sera were analysed for the presence of IgG antibodies to
C. burnetii phase II antigen, using a commercial ELISA
(Serion ELISA classic, Virion/Serion, Würzburg,
Germany). IgG antibodies were measured quantitatively
and the results generated from standard curves were
reported in International Units/ml. In line with
manufacturer’s recommendations, samples with values
of < 20 IU/ml were considered negative, values of 20–
30 IU/ml were scored as borderline, and those that had
values of > 30 IU/ml were considered as positive.
Statistical analysis
Based on the participants’ place of residence, we calcu-
lated the seroprevalence of antibodies against C. burnetii
by municipality. Municipalities with less than 10 partici-
pants were excluded. The chi-square test was used to
test for differences in C. burnetii seroprevalence between
municipalities. The relationship between the seropreva-
lence of antibodies against C. burnetii and the incidence
of Q fever notifications during the 2007–2010 Q fever
epidemic was assessed at municipal level by calculating
the Spearman correlation coefficient. A p-value of < 0.05
was considered significant. We examined the association
between farm exposures and C. burnetii seroprevalence
using log-binominal regression models and calculated
adjusted prevalence ratios (PRs) for the outcome ELISA
positive and borderline combined versus ELISA negative.
We incorporated cluster-robust standard errors to ac-
count for clustering at study centre level. Analyses
were adjusted for age (categorized as < 40, 40–60 and
> 60 years old), gender, educational level (categorized
as low, middle and high) and smoking (ever smoked,
yes/no). The presence of a certain type of animal
farm was adjusted for the presence of farms with
other animal species. The number of farm animals of
a species was adjusted for the presence of other farm
animal species. Co-linearity between independent vari-
ables was checked prior to regression analysis. Partici-
pants who had moved to the study area after 2010
were excluded. In a sensitivity analysis, samples with
Fig. 1 The seroprevalence of antibodies against C. burnetii in March 2014 to February 2015, dairy goat density per km2 in 2009, and the incidence
of Q fever notifications in the period 2007–2010, by municipality, region Noord-Brabant and the northern part of region Limburg, the Netherlands
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borderline values of 20–30 IU/ml were excluded.
Statistical analyses were performed with STATA v13.0
software (StataCorp, College Station, Texas).
Results
The overall seroprevalence of IgG antibodies against phase
II of C. burnetii was 6.1% (n = 139, 95% CI 5.1–7.1). The
median age for participants positive for antibodies
against C. burnetii was 59 years (interquartile range
[IQR] 48–66 years old); 76 (52.1%) of them were male.
A total of 126 participants were excluded because they
had moved to the study area after 2010.
Spatial distribution
The spatial distribution of goats, incidence of Q fever
notifications and seroprevalence of antibodies against C.
burnetii are displayed in Figure 1. At municipality level,
the seroprevalence of antibodies against C. burnetii
ranged from 1.7 to 14.1% and was significantly different
between municipalities (p < 0.001) (Table 1). There was a
positive correlation between C. burnetii seroprevalence
and Q fever incidence during the 2007–2010 epidemic
but this was not significant (rs = 0.42, p = 0.156).
Risk factors for C. burnetii infection
Seroprevalence of IgG antibodies against phase II of C.
burnetii was higher among those residing within 1000 m
of a goat farm (prevalence 15%, PR 3.0; 95% CI 1.4–6.4)
or within 1000 m of more than 50 goats (prevalence
11%, PR 1.9; 95% CI 1.2–3.0) (Table 2). Residing within
1000 m of a goat farm was still associated with sero-
prevalence when excluding Q fever affected goat farms
(data not shown). Seroprevalence increased with de-
creasing distance from the residential address to the
closest Q fever affected goat farm (< 500 m, prevalence
50%, PR 9.5, 95% CI 2.8–32; 500–1000 m, prevalence
25%, PR 4.5, 95% CI 2.6–7.7; 1000–1500 m, prevalence
12%, PR 2.2, 95%CI 1.1–4.3, 1500–2000 m, prevalence
7.0%, PR 1.2, 95% CI 0.6–2.5; > 2000 reference group,
prevalence 5.4%). The strength of the association did not
change in stratified analysis by goat farms that experi-
enced abortion storms and goat farms that only tested
positive for C. burnetii in bulk milk samples (data not
shown). Exposure variables related to sheep and cattle
were not significantly associated with the presence of
antibodies against C. burnetii.
Sensitivity analysis
In sensitivity analysis, 48 participants with ELISA bor-
derline results were excluded. A decreasing distance to
the closest Q fever affected goat farm was still associated
with increasing seroprevalence (<500 m, prevalence 50%,
PR 13.7, 95% CI 4.8–39; 500–1000 m, prevalence 14%,
PR 3.7, 95% CI 1.9–7.3; 1000–1500 m, prevalence 7.0%,
PR 1.9, 95% CI 1.2–3.2; 1500–2000 m, prevalence 3.0%,
PR 0.8, 95% CI 0.4–1.7; >2000 m reference group, preva-
lence 3.8%).
Table 1 Q fever incidence in the period 2007–2010 and serological results for antibodies against C. burnetii, by municipality, the
Netherlands, 10 March 2014–27 February 2015a






Boxmeer 28,610 87 10/71 14.1 (7.0–24.4)
Weert 48,330 0 18/164 11.0 (6.6–16.8)
Bernheze 29,620 797 32/301 10.6 (7.3–14.7)
Bergen 13,400 37 4/38 10.5 (2.9–24.8)
Sint-Michielsgestel 28,270 195 4/40 10.0 (2.8–23.7)
Sint Anthonis 11,790 136 22/288 7.6 (4.8–11.3)
Gemert-Bakel 28,510 95 21/308 6.8 (4.3–10.2)
Boxtel 30,280 73 6/149 4.0 (1.5–8.6)
Leudal 36,750 3 5/134 3.7 (1.2–8.5)
Someren 18,230 16 5/175 2.9 (0.9–6.5)
Deurne 31,470 13 2/104 1.9 (0.2–6.8)
Asten 16,360 37 6/326 1.8 (0.7–4.0)
Cranendonck 20,270 5 3/174 1.7 (0.4–5.0)
Overall 527,600 123 139/2296 6.1 (5.1–7.1)
aSpearman correlation coefficient between Q fever incidence during the 2007–2010 epidemic and C. burnetii seroprevalence was not significant
(rs = 0.42, p = 0.156)
bMunicipalities with < 10 participants are not displayed
cPer 100,000 population
d95% confidence interval (CI)
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However, the presence of goat farms or more than 50
goats within 1000 m of the participants’ residential ad-
dress were no longer significantly associated with an in-
creased prevalence of antibodies against C. burnetii
(prevalence 7.5%, PR 2.0; 95% CI 0.7–5.5 and prevalence
5.5%, PR 1.4; 95% CI 0.8–2.3, respectively). Variables re-
lated to exposure to sheep and cattle were not signifi-
cantly associated with antibodies against C. burnetii.
Discussion
We found significant differences in the seroprevalence of
antibodies against C. burnetii among municipalities in a rela-
tively small livestock-dense area, ranging from 1.7 to 14.1%
between municipalities. The seroprevalence of antibodies
against C. burnetii was significantly associated with living
close to goats and goat farms, especially those farms affected
by Q fever during the 2007–2010 Q fever epidemic.
Table 2 Adjusted prevalence ratios and corresponding 95% confidence intervals of the association between the presence of
antibodies against C. burnetii, and characteristics/exposures, the Netherlands, March 2014–February 2015
Participants (%) (n = 2296) Prevalence ratio (95% CI)a p-value
Age
< 40 years old 177 (7.7) Reference
40–60 years old 1045 (45.5) 1.0 (0.5–1.8) 0.93
> 60 years old 1074 (46.8) 1.1 (0.7–1.7) 0.77
Ever smoked 1262 (55.1) 0.8 (0.6–1.0) 0.09
Female gender 1240 (54.0) 0.8 (0.6–0.9) 0.01
Educational level
Low 592 (25.8) Reference
Middle 1027 (44.7) 0.8 (0.6–1.0) 0.03
High 677 (29.5) 0.7 (0.4–1.0) 0.06
Animal farms
Presence of Q fever affected goat farmb
within > 2000 m 2038 (88.8) Reference
within 1500–2000 m 139 (6.1) 1.2 (0.6–2.5) 0.53
within 1000–1500 m 91 (4.0) 2.2 (1.1–4.3) 0.02
within 500–1000 m 24 (1.1) 4.5 (2.6–7.7) < 0.01
within < 500 m 4 (0.2) 9.5 (2.8–31.6) < 0.01
Presence of goat farm (yes/no)
within 1000 mb 159 (6.9) 3.0 (1.4–6.4) < 0.01
within 500 mc 40 (1.7) 2.0 (0.7–5.7) 0.19
Presence of sheep farm (yes/no)
within 1000 mb 391 (17.0) 1.4 (0.7–2.8) 0.28
within 500 mc 120 (5.2) 1.2 (0.5–3.2) 0.69
Presence of cattle farm (yes/no)
within 1000 mb 2154 (93.8) 1.2 (0.5–3.3) 0.69
within 500 mc 1130 (49.2) 1.1 (0.9–1.4) 0.18
Farm animalsd
> 50 goats within 1000 m 249 (10.8) 1.9 (1.2–3.0) < 0.01
> 50 sheep within 1000 m 619 (27.0) 1.2 (0.7–2.0) 0.43
Number of cattle within 1000 m (tertiles)
≤ 314 752 (32.8) Reference
315–834 766 (33.4) 1.0 (0.6–1.6) 1.00
≥ 835 778 (33.9) 1.0 (0.7–1.5) 0.85
aAdjusted for gender, age (categorised as < 40, 40–60 and > 60 years old), educational level (low, middle and high), and smoking (ever smoked? yes/no)
bAdjusted for the presence of other animal farms within 1000 m (goat, sheep and cattle)
cAdjusted for the presence of other animal farms within 500 m (goat, sheep and cattle)
dAdjusted for the presence of other farm animals (goat, sheep and cattle)
entries in bold are all p-values
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Residential proximity to goats thus provides an explan-
ation for the spatial variation. However, the seropreva-
lence of C. burnetii antibodies in some of the
municipalities was lower than expected in this livestock-
dense area. Some of the municipalities had a seropreva-
lence that was equal or lower than the seroprevalence in
the general population before the Q fever epidemic from
2007 to 2010 [9]. In 2006, 1.5% of the general population
tested positive for C. burnetii antibodies using the same
diagnostic test as the current study. The seroprevalence
in the current study is probably an under-estimation of
the actual number of infections that occurred during the
outbreak. First, the ELISA used in the current study has
a lower sensitivity and similar specificity compared with
the IFA, which is considered the reference method for
diagnostic screening of C. burnetii antibodies [16]. For
instance, the ELISA seroprevalence estimate of 1.5% in
the general population in 2006 in the Netherlands was
adjusted to 2.4%, based on confirmation with IFA results
in a sub-set [9]. Second, Q fever patients can sero-revert
from IFA-positive to IFA-negative in the years after a Q
fever outbreak [17, 18]. In a study conducted in 2014 in
the general adult population in the village where the first
Q fever outbreak was reported, with a seroprevalence of
33.8%, 16.9% of the participants sero-reverted from IFA-
positive to IFA-negative in the years after the outbreak
[17]. The temporal dynamics of C. burnetii seropreva-
lence is difficult to interpret, as demonstrated by a study
of secular trends in C. burnetii antibody prevalence in
the Netherlands, which showed much higher seropreva-
lence in the general population in the 1980s [19].
Earlier studies already identified that living close to
goat farms is the most important risk factor for Q fever
[20–22]. In the present study, these findings were con-
firmed. Moreover, the association with seroprevalence
was even stronger for Q fever affected goat farms. This
is plausible, as a high number of C. burnetii are shed
with abortion, resulting in increased human exposure
[2]. This was underlined by the increasing seropreva-
lence with decreasing distance from the residential ad-
dress to the closest Q fever affected goat farm. We
expected a stronger association with the presence of C.
burnetii antibodies for goat farms that experienced abor-
tions than for farms that were only positive in tank milk
monitoring. However, some farms that tested positive in
tank milk had also experienced abortion waves. Further-
more, the last farm with Q fever-induced abortions was
in 2009 while the last goat farm was declared negative
only in 2016. The association between living close to
goat farms or with more than 50 goats within 1000 m
from the residential address and having C. burnetii anti-
bodies was no longer significant in sensitivity analysis al-
though it showed a positive association. This is probably
due to decreased statistical power as participants with
borderline ELISA results were excluded. Moreover, the
increasing seroprevalence with decreasing distance from
the residential address to the closest Q fever affected
goat farm was significant in the sensitivity analysis.
Exposure variables related to cattle were not associated
with the seroprevalence of antibodies against C. burnetii.
This could be explained by differences in C. burnetii
shedding patterns that may account for the more fre-
quent identification of goats than cattle as source of hu-
man Q fever [23]. While the main clinical symptom of
Q fever in cattle is infertility, Q fever in goats is mainly
associated with abortion. As previously mentioned, birth
products are associated with larger numbers of C. burne-
tii, while smaller numbers are excreted in urine, faeces
and milk [2]. Human exposure to C. burnetii from cattle
might therefore be limited, although more than half
(57%) of 344 dairy cattle herds tested positive for C.
burnetii using PCR on bulk tank milk in the Netherlands
in the period 2005–2006 [20]. In line with our findings,
isolates from cattle showed different genotypes than those
in goats, sheep and humans in the Netherlands during the
Q fever epidemic, although data is sparse [24].
No association was found between sheep-related expos-
ure variables and the presence of antibodies against C.
burnetii. This is probably due to the lower number of
sheep farms that were bulk milk-positive for C. burnetii
using PCR compared with goat farms. The implemented
mandatory bulk milk monitoring scheme that was carried
out since October 2009 indicated that 96 (27%) large dairy
goat farms and 2 (5%) dairy sheep farms had tested bulk
milk-positive for C. burnetii by April 2011 [25, 26].
Although the C. burnetii seroprevalence was positively
correlated with Q fever incidence during the period
2007–2010 at municipality level, this correlation was not
significant. This was mainly due to one municipality,
Weert, where the seroprevalence was high, while no hu-
man Q fever cases were reported from that municipality
during the epidemic. When we excluded this municipal-
ity, the Spearman correlation between the C. burnetii
seroprevalence and Q fever incidence during the period
2007–2010 was significant (rs = 0.75, p = 0.005). Exclud-
ing any of the other municipalities did not alter the
Spearman correlation coefficient. There were Q fever af-
fected dairy goat farms in and around the municipality
of Weert. The possible reasons for the lack of Q fever
cases while the observed C. burnetii seroprevalence was
high included: 1) lower infectious doses emitted from
the farms; 2) local environmental conditions that were
less conducive for transport of bacteria through the air
at the time of the abortion storm on the farm; 3) a less
virulent strain of C. burnetii than elsewhere; and 4)
under-diagnosis and/or under-reporting of human cases
by general practitioners. An earlier study reported that
each acute Q fever notification represented ≥ 12 incident
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Q fever infections [27]. This is likely primarily due to
asymptomatic infections, undiagnosed symptomatic in-
fections and laboratory-confirmed infections that did
not fulfil the clinical criteria for notification.
Conclusions
The study indicates remarkable spatial variation in C.
burnetii seroprevalence within a relatively small area. This
variation can largely be attributed to differences in trans-
mission intensity during the 2007–2010 epidemic. Our
results add to the pool of evidence that the Q fever epi-
demic was primarily the result of airborne C. burnetii
transmission from Q fever affected goat farms. Although
the vaccination of goats has shown to be effective in redu-
cing shedding of bacteria, C. burnetii can survive in the
environment for years and has been detected in ambient
air after the Q fever outbreak [28]. Therefore, physicians
should remain vigilant for human Q fever cases despite
the marked decrease in notifications since the epidemic.
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